, GBD Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study, Lancet, vol.385, issue.9963, pp.117-171, 2013.
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study, Lancet Gastroenterol Hepatol, vol.2, issue.3, pp.161-176, 2017. ,
, Towards the elimination of hepatitis B and C by 2030, 2016.
, World Health Organisation. Guidelines for the Screening, Care and Treatment of Persons with Chronic Hepatitis C Infection. Updated version, 2016.
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews, Lancet, vol.378, issue.9791, pp.571-583, 2011. ,
, United Nations Office on Drugs and Crime. Afghan opiate trafficking through the Southern route
, United Nations Office on Drugs and Crime. Transnational Organised Crime in East Africa: A Threat Assessment, vol.2013, p.4
, New treatment gives hope to East Africa's drug users, Bull World Health Organ, vol.91, pp.89-90, 2013.
Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study, J Int AIDS Soc, vol.18, 2015. ,
An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Int J Drug Policy, vol.24, issue.1, pp.78-81, 2011. ,
World Health Organisation drug injecting study Phase II Findings, HBV and HCV in injecting drug users in, 2004. ,
Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania, Int J Drug Policy, vol.45, pp.64-69, 2017. ,
Breaking down barriers to care in hepatitis C virus infection, J Infect Dis, vol.213, issue.7, pp.1055-1056, 2016. ,
Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt, J Viral Hepat, vol.22, issue.3, pp.245-253, 2015. ,
Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio to predict liver fibrosis in Egyptian patients with HCV genotype 4, Gut, vol.65, issue.9, pp.1577-1578, 2016. ,
The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa, Gut, vol.65, issue.8, pp.1369-1376, 2016.,
URL : https://hal.archives-ouvertes.fr/pasteur-02875304
Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C, Aliment Pharmacol Ther, vol.30, issue.6, pp.557-576, 2009. ,
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis, Ultrasound Med Biol, vol.29, issue.12, pp.1705-1713, 2003. ,
Determination of reliability criteria for liver stiffness evaluation by transient elastography, Hepatology, vol.57, issue.3, pp.1182-1191, 2013.,
URL : https://hal.archives-ouvertes.fr/hal-02517170
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin, Gastroenterology, vol.131, issue.4, pp.1040-1048, 2006. ,
Prevalence of hepatitis C virus and its genotypes among a cohort of drug users in Kenya, East Afr Med J, vol.85, issue.7, pp.318-325, 2008. ,
, United Nations Office on Drugs and Crime. World Drug Report, 2015.
Awareness of HCV infection among persons who inject drugs in, Am J Public Health, vol.105, issue.2, pp.302-303, 2015. ,
Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study, Clin Infect Dis, vol.58, issue.6, pp.755-761, 2014. ,
Simplified HCV Diagnostics, 2016. ,
Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis, Ann Intern Med, vol.165, issue.5, pp.345-355, 2016. ,
HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study, J Int AIDS Soc, vol.20, issue.1, pp.1-8, 2017.,
URL : https://hal.archives-ouvertes.fr/hal-01536669
Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in, J Int AIDS Soc, vol.20, issue.1, p.21856, 2017.,
URL : https://hal.archives-ouvertes.fr/pasteur-02875248
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncturecollected and finger-stick capillary whole-blood samples: a cohort study, Lancet Gastroenterol Hepatol, vol.2, issue.7, pp.514-520, 2017. ,
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study, Int J Drug Policy, vol.26, issue.10, pp.984-991, 2015. ,
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection, Clin Infect Dis, vol.48, issue.7, pp.963-972, 2009. ,
Outreach screening of drug users for cirrhosis with transient elastography, Addiction, vol.106, issue.5, pp.970-976, 2011. ,
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nat Genet, vol.40, issue.12, pp.1461-1465, 2008. ,
Is aspartate aminotransferase-toplatelet ratio index a reliable tool in human immunodeficiency virus patients in Africa?, Liver Int, vol.35, issue.8, p.2059, 2015. ,
Usual APRI Score Thresholds Lack Sensitivity to Prioritise for Hepatitis C Treatment in a HCV/HIV Coinfected Cohort in Cambodia, 2017. ,
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy, Clin Infect Dis, vol.57, issue.2, pp.39-45, 2013. ,
Harm reduction for young people who use prescription opioids extra-medically: obstacles and opportunities, Int J Drug Policy, vol.31, pp.25-31, 2016. ,
Preventing HIV and hepatitis infections among people who inject drugs: leveraging an indiana outbreak response to break the impasse, AIDS Behav, vol.21, issue.4, pp.968-972, 2017. ,
Tanzania project summary ,
, The World Bank, 2016.
, World Health Organisation, 2017.
, World Health Organisation. WHO prequalifies first generic active ingredient for hepatitis C medicines, 2017.
The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, J Viral Hepat, vol.25, pp.1438-1445, 2013.,
URL : https://hal.archives-ouvertes.fr/pasteur-02875234